For early and advanced breast cancer in pre- and post-menopausal women, Nolvadex-Tamoxifen Citrate has been used within 10 million patients yearly. The US Food and Drug Administration (FDA) approved Nolvadex-Tamoxifen Citrate in 1998 for lessening the occurrence of breast cancer in women, which are at higher risk of developing the disease.
Nolvadex-Tamoxifen Citrate is also prescribed to lessen the risk of invasive breast cancer following surgery and radiation therapy for ductal carcinoma in situ. It doesnt annihilate the risks totally, but in a five-year study of more than 1,500 high-risk women, it gashed the number of cases by 44 percent.
Nolvadex-Tamoxifen Citrate raises the chances of developing uterine cancer. Women taking Nolvadex-Tamoxifen Citrate should contact their doctors routinely to have gynecological examinations. They can make contact with doctor at once, if they notice abnormal vaginal bleeding, changes in menstrual periods change in vaginal discharge, or pelvic pain or pressure. Other side effects linked with Nolvadex-Tamoxifen Citrate include hot flashes, nausea and vomiting.
Take Nolvadex-Tamoxifen Citrate correctly as prescribed. Dont...
To view and download this full PLR article, you must be logged in. Registration is completely free. Once you create your account, you will be able to browse, search & downlod from our PLR articles database of over "1,57,897+" on 1,000's of niches and 200+ categories without paying a penny. Click here to signup...
